Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line

Abstract

The dynamic balance between histone acetylation and deacetylation plays a significant role in the regulation of gene transcription. Much of our current understanding of this transcriptional control comes from the use of HDAC inhibitors such as trapoxin A (TPX), which leads to hyperacetylated histone, alters local chromatin architecture and transcription and results in tumor cell death. In this study, we treated tumor cells with TPX and HDAC1 antisense oligonucleotides, and analysed the transcriptional consequences of HDAC inhibition. Among other genes, the small GTPase RhoB was found to be significantly upregulated by TPX and repressed by HDAC1. The induction of RhoB by HDAC inhibition was mediated by an inverted CCAAT box in the RhoB promoter. Interestingly, measurement of RhoB transcription in 130 tumor-derived cell lines revealed low expression in almost all of these samples, in contrast to RhoA and RhoC. Accumulating evidence indicates that the small GTPase Rho proteins are involved in a variety of important processes in cancer, including cell transformation, survival, invasion, metastasis and angiogenesis. This study for the first time demonstrates a link between HDAC inhibition and RhoB expression and provides an important insight into the mechanisms of HDAC-mediated transcriptional control and the potential therapeutic benefit of HDAC inhibition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Adnane J, Muro-Cacho C, Mathews L, Sebti SM and Munoz-Antonia T . (2002). Clin. Cancer Res., 8, 2225–2232.

  • Bertos NR, Wang AH and Yang XJ . (2001). Biochem. Cell Biol., 79, 243–252.

  • Boyd KE, Wells J, Gutman J, Bartley SM and Farnham PJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 13887–13892.

  • Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA and Richon VM . (2002). Proc. Natl. Acad. Sci. USA, 20, 20.

  • Chen H, Tini M and Evans RM . (2001a). Curr. Opin. Cell Biol., 13, 218–224.

  • Chen L, Fischle W, Verdin E and Greene WC . (2001b). Science, 293, 1653–1657.

  • Chen Z, Sun J, Pradines A, Favre G, Adnane J and Sebti SM . (2000). J. Biol. Chem., 275, 17974–17978.

  • Clark EA, Golub TR, Lander ES and Hynes RO . (2000). Nature, 406, 532–535.

  • Du W and Prendergast GC . (1999). Cancer Res., 59, 5492–5496.

  • Engel ME, Datta PK and Moses HL . (1998). J. Biol. Chem., 273, 9921–9926.

  • Fritz G and Kaina B . (1997). J. Biol. Chem., 272, 30637–30644.

  • Fritz G and Kaina B . (2000). Biochem. Biophys. Res. Commun., 268, 784–789.

  • Fritz G and Kaina B . (2001a). J. Biol. Chem., 276, 3115–3122.

  • Fritz G and Kaina B . (2001b). Nucleic Acids Res., 29, 792–798.

  • Fritz G, Kaina B and Aktories K . (1995). J. Biol. Chem., 270, 25172–25177.

  • Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida M and Horinouchi S . (2001). Proc. Natl. Acad. Sci. USA, 98, 87–92.

  • Gray SG and Ekstrom TJ . (2001). Exp Cell Res., 262, 75–83.

  • Grunstein M . (1997). Nature, 389, 349–352.

  • Imai S, Armstrong CM, Kaeberlein M and Guarente L . (2000). Nature, 403, 795–800.

  • Jahner D and Hunter T . (1991). Mol. Cell. Biol., 11, 3682–3690.

  • Jin S and Scotto KW . (1998). Mol. Cell. Biol., 18, 4377–4384.

  • Jones PL, Sachs LM, Rouse N, Wade PA and Shi YB . (2001). J. Biol. Chem., 276, 8807–8811.

  • Kamai T, Arai K, Tsujii T, Honda M and Yoshida K . (2001). BJU Int., 87, 227–231.

  • Khochbin S, Verdel A, Lemercier C and Seigneurin-Berny D . (2001). Curr. Opin. Genet. Dev., 11, 162–166.

  • Liu A . (2001). Proc. Natl. Acad. Sci. USA, 98, 6192–6197.

  • Liu A and Prendergast GC . (2000). FEBS Lett., 481, 205–208.

  • Liu AX, Rane N, Liu JP and Prendergast GC . (2001). Mol. Cell. Biol., 21, 6906–6912.

  • Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD and Berger SL . (1999). Mol. Cell. Biol., 19, 1202–1209.

  • Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T and Kelly WK . (2001). Nat. Rev. Cancer, 1, 194.

  • Moreno CS, Beresford GW, Louis-Plence P, Morris AC and Boss JM . (1999). Immunity, 10, 143–151.

  • Nakatani Y . (2001). Genes Cells, 6, 79–86.

  • Park SH, Lee SR, Kim BC, Cho EA, Patel SP, Kang HB, Sausville EA, Nakanishi O, Trepel JB, Lee BI and Kim SJ . (2002). J. Biol. Chem., 277, 5168–5174.

  • Pazin MJ and Kadonaga JT . (1997). Cell, 89, 325–328.

  • Prendergast GC . (2001). Nat. Rev. Cancer, 1, 162.

  • Sahai E and Marshall CJ . (2002). Nat. Rev. Cancer, 2, 133–142.

  • Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H and Cohen D . (1999). J. Biol. Chem., 274, 34940–34947.

  • Strahl BD and Allis CD . (2000). Nature, 403, 41–45.

  • Takai Y, Sasaki T and Matozaki T . (2001). Physiol. Rev., 81, 153–208.

  • van Golen KL, Wu ZF, Qiao XT, Bao LW and Merajver SD . (2000). Cancer Res., 60, 5832–5838.

  • Van Lint C, Emiliani S and Verdin E . (1996). Gene Expr., 5, 245–253.

  • Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L and Weinberg RA . (2001). Cell, 107, 149–159.

  • Weidle UH and Grossmann A . (2000). Anticancer Res., 20, 1471–1485.

  • Welsh JB . (2001). Cancer Res., 61, 5974–5978.

  • Yoshioka K, Nakamori S and Itoh K . (1999). Cancer Res., 59, 2004–2010.

  • Zhou X, Marks PA, Rifkind RA and Richon VM . (2001). Proc. Natl. Acad. Sci. USA, 98, 10572–10577.

Download references

Acknowledgements

We thank R Kramer for reviewing the manuscript, and E Verdin for providing HDAC6 expression vector (Chen et al., 2001b).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dalia Cohen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, S., Yan-Neale, Y., Fischer, D. et al. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene 22, 6204–6213 (2003). https://doi.org/10.1038/sj.onc.1206653

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206653

Keywords

This article is cited by

Search

Quick links